Data on Type 2 Diabetes Reported by Researchers at Yonsei University College of Medicine (Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus)

MLA

“Data on Type 2 Diabetes Reported by Researchers at Yonsei University College of Medicine (Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus).” Obesity, Fitness & Wellness Week, Dec. 2019, p. 68. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.607195147&authtype=sso&custid=ns315887.

APA

Data on Type 2 Diabetes Reported by Researchers at Yonsei University College of Medicine (Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus). (2019, December 7). Obesity, Fitness & Wellness Week, 68.

Chicago

Obesity, Fitness & Wellness Week. 2019. “Data on Type 2 Diabetes Reported by Researchers at Yonsei University College of Medicine (Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus),” December 7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.607195147&authtype=sso&custid=ns315887.